Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0001209191-17-007070)

Filing Details

Accession Number:
0001209191-17-007070
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-02-02 16:10:36
Reporting Period:
2017-01-31
Filing Date:
2017-02-02
Accepted Time:
2017-02-02 16:10:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1000694 Novavax Inc NVAX Biological Products, (No Disgnostic Substances) (2836) 222816046
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1265801 A Barclay Phillips C/O Novavax, Inc.
20 Firstfield Road
Gaithersburg MD 20878		 Svp, Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-01-31 1,633 $1.12 11,612 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Includes 1,633 shares acquired under the Issuer's Amended and Restated 2013 Employee Stock Purchase Plan on January 31, 2017.